Par Pharmaceutical Inc. recalls Frovatriptan Succinate Tablets, 2.5mg, packaged in 1 blister card of 9 tablets per carton, Rx Only, Manufactured by: Al…
- Recall date
- February 10, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0843-2020
- FDA classification
- Class III
- Brand / firm
- Par Pharmaceutical Inc.
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Labeling: Incorrect or Missing Lot and/or Exp Date: Product incorrectly labeled with an expiration date of August 2022 rather than the correct expiration date of April 2022.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Frovatriptan Succinate Tablets, 2.5mg, packaged in 1 blister card of 9 tablets per carton, Rx Only, Manufactured by: Almac Pharma Services Limited, Craigavon, BT63 5UA, UK; Manufactured for: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 0603-3718-34.
Get recall alerts
Free email alert whenever Par Pharmaceutical Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Par Pharmaceutical Inc.